<!DOCTYPE html>
<html lang="en">

<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Pharmacological Interventions: Understanding the Evidence</title>
 <style>
 /* Base & Reset */
 * {
 box-sizing: border-box;
 }

 body {
 font-family: Georgia, 'Times New Roman', serif;
 line-height: 1.8;
 color: #2d2d2d;
 background: #f8f6f3;
 margin: 0;
 padding: 0;
 }

 /* Main Container */
 .lesson-container {
 max-width: 860px;
 margin: 0 auto;
 padding: 40px 30px;
 background: #ffffff;
 min-height: 100vh;
 box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
 }

 /* Module Header - GREEN theme for PCOS */
 .module-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 35px 35px 30px;
 border-radius: 16px;
 margin-bottom: 30px;
 position: relative;
 overflow: hidden;
 }

 .module-header::before {
 content: '';
 position: absolute;
 top: 0;
 right: 0;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
 transform: translate(100px, -100px);
 }

 .module-header::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 100%;
 height: 4px;
 background: #B8860B;
 }

 .module-label {
 margin: 0;
 font-size: 11px;
 color: rgba(255, 255, 255, 0.75);
 text-transform: uppercase;
 letter-spacing: 2.5px;
 font-weight: 500;
 }

 .lesson-title {
 margin: 10px 0 0 0;
 font-size: 28px;
 color: #ffffff;
 font-weight: 700;
 line-height: 1.3;
 position: relative;
 }

 .lesson-meta {
 display: flex;
 gap: 12px;
 margin-top: 20px;
 padding-top: 18px;
 border-top: 1px solid rgba(255, 255, 255, 0.15);
 flex-wrap: wrap;
 }

 .meta-item {
 display: flex;
 align-items: center;
 gap: 6px;
 font-size: 12px;
 color: rgba(255, 255, 255, 0.85);
 background: rgba(255, 255, 255, 0.1);
 padding: 5px 12px;
 border-radius: 4px;
 }

 /* Table of Contents */
 .toc-box {
 background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
 border-radius: 14px;
 padding: 24px 28px;
 margin-bottom: 35px;
 border: 1px solid #e8e8e8;
 }

 .toc-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 padding-bottom: 12px;
 border-bottom: 1px solid #e0e0e0;
 }

 .toc-list {
 list-style: none;
 margin: 0;
 padding: 0;
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 8px 24px;
 }

 .toc-list li {
 margin: 0;
 }

 .toc-list a {
 display: flex;
 align-items: center;
 padding: 8px 12px;
 color: #555;
 text-decoration: none;
 font-size: 14px;
 border-radius: 6px;
 transition: all 0.2s ease;
 }

 .toc-list a:hover {
 background: white;
 color: #047857;
 box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
 }

 .toc-list .section-num {
 display: inline-flex;
 align-items: center;
 justify-content: center;
 width: 26px;
 height: 26px;
 background: #047857;
 color: white;
 font-weight: 600;
 font-size: 11px;
 border-radius: 6px;
 margin-right: 12px;
 flex-shrink: 0;
 }

 @media (max-width: 600px) {
 .toc-list {
 grid-template-columns: 1fr;
 }
 }

 /* Learning Objectives */
 .objectives-box {
 background: #ecfdf5;
 border: 2px solid #047857;
 border-radius: 14px;
 padding: 30px 35px;
 margin-bottom: 40px;
 }

 .objectives-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 display: flex;
 align-items: center;
 gap: 10px;
 }

 .objectives-box .box-label::before {
 content: 'üéØ';
 font-size: 18px;
 }

 .objectives-box ul {
 margin: 0;
 padding-left: 22px;
 }

 .objectives-box li {
 margin-bottom: 14px;
 font-size: 16px;
 line-height: 1.7;
 }

 .objectives-box li:last-child {
 margin-bottom: 0;
 }

 /* Key Terms Box */
 .key-terms-box {
 background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
 border-radius: 14px;
 padding: 28px 30px;
 margin: 40px 0;
 border: 1px solid #d8dce0;
 }

 .key-terms-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .terms-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 }

 .term-item {
 background: white;
 padding: 16px 18px;
 border-radius: 10px;
 border-left: 4px solid #047857;
 }

 .term-item .term {
 font-weight: 700;
 color: #047857;
 font-size: 15px;
 margin: 0 0 6px 0;
 }

 .term-item .definition {
 font-size: 14px;
 color: #555;
 margin: 0;
 line-height: 1.6;
 }

 /* Section Headings */
 h2 {
 font-size: 24px;
 color: #047857;
 margin: 50px 0 20px 0;
 font-weight: 600;
 position: relative;
 padding-bottom: 12px;
 }

 h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 3px;
 background: #B8860B;
 }

 /* Paragraphs */
 p {
 font-size: 17px;
 margin-bottom: 20px;
 color: #333;
 }

 /* Highlights */
 .highlight {
 background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
 padding: 0 4px;
 font-weight: 500;
 color: inherit; /* Ensures text color inherits from parent */
 }

 /* Welcome/Intro Box */
 .welcome-box {
 background: linear-gradient(135deg, #ecfdf5 0%, #f7fef7 100%);
 padding: 30px 35px;
 border-radius: 14px;
 margin-bottom: 40px;
 border: 1px solid #bbf7d0;
 }

 .welcome-box h3 {
 margin: 0 0 15px 0;
 font-size: 20px;
 color: #047857;
 font-weight: 600;
 }

 .welcome-box p {
 margin: 0;
 font-size: 17px;
 line-height: 1.8;
 color: #444;
 }

 /* Alert Boxes */
 .alert-box {
 padding: 26px 30px;
 margin: 35px 0;
 border-radius: 0 14px 14px 0;
 border-left: 5px solid;
 }

 .alert-box .alert-label {
 font-weight: 600;
 margin: 0 0 12px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .alert-box p:last-child {
 margin: 0;
 font-size: 16px;
 line-height: 1.7;
 }

 .alert-box.warning {
 background: #fff8e6;
 border-left-color: #ff9800;
 }

 .alert-box.warning .alert-label {
 color: #e65100;
 }

 .alert-box.success {
 background: #f0f8f0;
 border-left-color: #4caf50;
 }

 .alert-box.success .alert-label {
 color: #2e7d32;
 }

 .alert-box.reflect {
 background: #f8f0fa;
 border-left-color: #9c27b0;
 }

 .alert-box.reflect .alert-label {
 color: #7b1fa2;
 }

 .alert-box.info {
 background: #e3f2fd;
 border-left-color: #2196f3;
 }

 .alert-box.info .alert-label {
 color: #1565c0;
 }

 /* Case Study Box */
 .case-study {
 background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
 border-radius: 16px;
 padding: 0;
 margin: 40px 0;
 overflow: hidden;
 box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
 }

 .case-study-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 20px 30px;
 display: flex;
 align-items: center;
 gap: 15px;
 }

 .case-study-icon {
 width: 45px;
 height: 45px;
 background: rgba(255, 255, 255, 0.15);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 }

 .case-study-header .box-label {
 font-weight: 600;
 color: #ffffff;
 margin: 0;
 font-size: 16px;
 letter-spacing: 0.5px;
 }

 .case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 13px;
 margin: 4px 0 0 0;
 }

 .case-study-content {
 padding: 28px 30px;
 }

 .case-study-content p {
 font-size: 16px;
 margin-bottom: 18px;
 }

 .case-study-content ul {
 margin: 18px 0;
 padding-left: 22px;
 }

 .case-study-content li {
 margin-bottom: 10px;
 font-size: 15px;
 }

 .patient-profile {
 display: flex;
 align-items: center;
 gap: 18px;
 padding: 18px 22px;
 background: white;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e5e5;
 }

 .patient-avatar {
 width: 55px;
 height: 55px;
 background: linear-gradient(135deg, #059669, #047857);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 flex-shrink: 0;
 }

 .patient-info h4 {
 margin: 0 0 5px 0;
 font-size: 17px;
 color: #1a1a1a;
 }

 .patient-info p {
 margin: 0;
 font-size: 14px;
 color: #666;
 }

 /* Comparison Cards */
 .comparison-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 20px;
 margin: 30px 0;
 }

 .comparison-card {
 border-radius: 14px;
 padding: 26px;
 border-top: 5px solid;
 transition: transform 0.2s ease;
 }

 .comparison-card:hover {
 transform: translateY(-3px);
 }

 .comparison-card.conventional {
 background: #fff5f5;
 border-top-color: #c62828;
 }

 .comparison-card.functional {
 background: #f1f8f1;
 border-top-color: #2e7d32;
 }

 .comparison-card .card-label {
 font-weight: 600;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 margin: 0 0 14px 0;
 }

 .comparison-card.conventional .card-label {
 color: #c62828;
 }

 .comparison-card.functional .card-label {
 color: #2e7d32;
 }

 .comparison-card .card-text {
 margin: 0;
 font-size: 16px;
 font-style: italic;
 line-height: 1.6;
 }

 /* Content Lists */
 .content-list {
 font-size: 17px;
 margin: 20px 0;
 padding-left: 24px;
 }

 .content-list li {
 margin-bottom: 14px;
 line-height: 1.7;
 }

 .content-list li:last-child {
 margin-bottom: 0;
 }

 /* Statistics Box */
 .stats-box {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 40px;
 border-radius: 16px;
 margin: 35px 0;
 position: relative;
 overflow: hidden;
 }

 .stats-box::before {
 content: '';
 position: absolute;
 top: -50%;
 right: -20%;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.08) 0%, transparent 70%);
 }

 .stats-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
 gap: 25px;
 position: relative;
 }

 .stat-item {
 text-align: center;
 }

 .stat-number {
 font-size: 42px;
 font-weight: 700;
 color: white;
 line-height: 1;
 margin-bottom: 8px;
 }

 .stat-label {
 font-size: 13px;
 color: rgba(255, 255, 255, 0.85);
 text-transform: uppercase;
 letter-spacing: 1px;
 }

 /* Principle Cards */
 .principle-card {
 background: linear-gradient(to right, #fafafa, #ffffff);
 border-left: 5px solid #047857;
 padding: 24px 28px;
 margin-bottom: 18px;
 border-radius: 0 14px 14px 0;
 box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
 transition: transform 0.2s ease, box-shadow 0.2s ease;
 }

 .principle-card:hover {
 transform: translateX(5px);
 box-shadow: 0 4px 18px rgba(0, 0, 0, 0.08);
 }

 .principle-card .principle-title {
 font-weight: 700;
 color: #047857;
 margin: 0 0 10px 0;
 font-size: 17px;
 }

 .principle-card .principle-text {
 margin: 0;
 font-size: 15px;
 line-height: 1.7;
 }

 .principle-card ul {
 margin: 12px 0 0 0;
 padding-left: 20px;
 font-size: 14px;
 }

 .principle-card li {
 margin-bottom: 5px;
 }

 /* Check Understanding Box */
 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }

 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }

 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }

 .reveal-btn {
 background: #047857;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }

 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #f0fdf4;
 border-radius: 8px;
 color: #166534;
 font-size: 16px;
 border-left: 4px solid #22c55e;
 }

 /* Key Takeaways */
 .takeaways-box {
 background: #047857;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }

 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }

 .takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 }

 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }

 /* Interactive Diagram */
 .interactive-diagram {
 background: white;
 border: 2px solid #e5e5e5;
 border-radius: 16px;
 padding: 30px;
 margin: 35px 0;
 text-align: center;
 }

 /* Footer */
 .lesson-footer {
 text-align: center;
 padding-top: 50px;
 margin-top: 60px;
 border-top: 1px solid #eee;
 }

 .footer-logo {
 max-width: 140px;
 height: auto;
 margin-bottom: 15px;
 opacity: 0.9;
 }

 .lesson-footer .brand {
 color: #047857;
 font-weight: 600;
 margin: 0;
 font-size: 15px;
 }

 .lesson-footer .copyright {
 color: #888;
 font-size: 13px;
 margin: 10px 0 0 0;
 }

 /* Responsive */
 @media (max-width: 768px) {
 .lesson-container {
 padding: 20px 16px;
 }

 .module-header {
 padding: 25px 20px 22px;
 }

 .lesson-title {
 font-size: 22px;
 }

 h2 {
 font-size: 20px;
 margin: 35px 0 15px 0;
 }

 p {
 font-size: 16px;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .objectives-box {
 padding: 25px 20px;
 }

 .key-terms-box {
 padding: 22px 18px;
 }

 .terms-grid {
 grid-template-columns: 1fr;
 }

 .stats-box {
 padding: 25px 20px;
 }

 .stat-number {
 font-size: 32px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .principle-card {
 padding: 20px;
 }

 .case-study-content {
 padding: 20px;
 }

 .check-understanding {
 padding: 25px 20px;
 }

 .takeaways-box {
 padding: 18px 20px;
 }

 .alert-box {
 padding: 20px;
 }

 .content-list {
 padding-left: 20px;
 font-size: 16px;
 }
 }

 @media (max-width: 480px) {
 .lesson-container {
 padding: 15px 12px;
 }

 .brand-logo {
 max-width: 180px;
 }

 .stats-grid {
 grid-template-columns: repeat(2, 1fr);
 gap: 15px;
 }
 }

 /* Data Table Styling */
 .data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
 .data-table th { background: #059669; color: white; padding: 12px 15px; text-align: left; }
 .data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
 .data-table tr:nth-child(even) { background: #f9fafb; }
 </style>
</head>

<body>
 <div class="lesson-container">
 <header class="module-header">
 <p class="module-label">Module 19: Research & Evidence</p>
 <h1 class="lesson-title">Pharmacological Interventions: Understanding the Evidence</h1>
 <div class="lesson-meta">
 <span class="meta-item">12 min read</span>
 <span class="meta-item">Lesson 7 of 8</span>
 </div>
 </header>

 <!-- Table of Contents -->
 <div class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#intro"><span class="section-num">1</span>Introduction</a></li>
 <li><a href="#metformin"><span class="section-num">2</span>Metformin: Evidence for PCOS Management</a></li>
 <li><a href="#fertility"><span class="section-num">3</span>Clomiphene Citrate and Letrozole: Fertility Support</a></li>
 <li><a href="#ocs"><span class="section-num">4</span>Oral Contraceptives: Symptom Management</a></li>
 <li><a href="#antiandrogens"><span class="section-num">5</span>Anti-Androgens: Addressing Hirsutism and Acne</a></li>
 <li><a href="#insulinsensitizers"><span class="section-num">6</span>Insulin Sensitizers: Thiazolidinediones</a></li>
 <li><a href="#shareddecisionmaking"><span class="section-num">7</span>Shared Decision-Making</a></li>
 </ul>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Review the evidence for the use of metformin, clomiphene citrate, letrozole, and oral contraceptives in managing PCOS symptoms and improving fertility.</li>
 <li>Evaluate the benefits and risks of different pharmacological interventions for PCOS, considering potential side effects and contraindications.</li>
 <li>Understand the evidence for the use of anti-androgen medications (e.g., spironolactone, finasteride) in managing hirsutism and acne in women with PCOS.</li>
 <li>Analyze the evidence for the use of insulin-sensitizing medications (e.g., thiazolidinediones) in managing insulin resistance and diabetes risk in PCOS.</li>
 <li>Understand the importance of shared decision-making with clients regarding pharmacological interventions, considering their individual preferences and values.</li>
 </ul>
 </div>

 <!-- Introduction -->
 <h2 id="intro">Introduction</h2>
 <p>Welcome to a critical lesson where we delve into the evidence surrounding pharmacological interventions for PCOS. As we've established throughout the <span class="highlight">T.H.R.I.V.E. Framework‚Ñ¢</span>, a comprehensive approach to PCOS often involves integrating lifestyle modifications with targeted medical treatments. This lesson builds on our previous discussions about evidence-based nutrition, exercise, and lifestyle interventions, providing a balanced perspective on when and how medications can play a supportive role.</p>

 <!-- Metformin -->
 <h2 id="metformin">Metformin: Evidence for PCOS Management</h2>
 <p>Metformin, a commonly prescribed medication for type 2 diabetes, has been widely studied for its effects on insulin resistance in PCOS. A 2017 Cochrane review of 27 trials (n=2,255) found that metformin, compared to placebo, was associated with improved menstrual regularity and ovulation rates in women with PCOS <span class="stat-highlight">(OR 3.57, 95% CI 2.42-5.26)</span>. It's important to note that while metformin can be beneficial, it's not a one-size-fits-all solution. Side effects like gastrointestinal upset are common, and its effectiveness can vary depending on individual factors.</p>

 <!-- Case Study: Maria, 43 -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
 <div class="box-label">Case Study: Maria, 43</div>
 <p class="subtitle">PCOS and Insulin Resistance</p>
 </div>
 <div class="case-study-content">
 <p>Maria, a 43-year-old woman, presented with irregular periods, weight gain, and elevated blood sugar levels. After implementing dietary changes and exercise as part of the <span class="highlight">Holistic Harmonization</span> phase of the <span class="highlight">T.H.R.I.V.E. Framework‚Ñ¢</span>, her insulin resistance remained a concern. Her physician prescribed metformin, which, in conjunction with her lifestyle changes, led to improved menstrual cycles and better blood sugar control.</p>
 </div>
 </div>

 <!-- Fertility Support -->
 <h2 id="fertility">Clomiphene Citrate and Letrozole: Fertility Support</h2>
 <p>For women with PCOS seeking fertility, clomiphene citrate and letrozole are commonly used ovulation-inducing agents. A 2014 meta-analysis published in <span class="highlight">The Lancet</span> found that letrozole was associated with higher live birth rates compared to clomiphene citrate in women with PCOS <span class="stat-highlight">(27.5% vs 19.1%, OR 1.58, 95% CI 1.20-2.07)</span>. However, it's crucial to discuss the potential risks of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS) with clients.</p>

 <!-- Oral Contraceptives -->
 <h2 id="ocs">Oral Contraceptives: Symptom Management</h2>
 <p>Oral contraceptives (OCs) are frequently prescribed to manage symptoms like irregular periods, acne, and hirsutism inwomen with PCOS. OCs work by regulating hormone levels, reducing androgen production, and providing predictable withdrawal bleeding. A systematic review by Arowojolu et al. (2009) concluded that OCs are effective in improving menstrual regularity and reducing hirsutism scores in women with PCOS.</p>

 <!-- Anti-Androgens -->
 <h2 id="antiandrogens">Anti-Androgens: Addressing Hirsutism and Acne</h2>
 <p>When OCs are insufficient to control hirsutism and acne, anti-androgen medications like spironolactone and finasteride may be considered. Spironolactone, for example, blocks androgen receptors and reduces androgen production. A 2015 study in the <span class="highlight">Journal of Clinical Endocrinology & Metabolism</span> found that spironolactone significantly reduced hirsutism scores compared to placebo after six months of treatment. It is crucial to discuss potential side effects such as diuresis and the need for effective contraception due to the risk of feminization of a male fetus.</p>

 <!-- Insulin Sensitizers -->
 <h2 id="insulinsensitizers">Insulin Sensitizers: Thiazolidinediones</h2>
 <p>While metformin is the most commonly used insulin sensitizer, thiazolidinediones (TZDs) like pioglitazone are another option. TZDs improve insulin sensitivity by acting on the PPARŒ≥ receptor. However, due to concerns about side effects such as weight gain, edema, and potential cardiovascular risks, TZDs are generally reserved for cases where other treatments have failed or are contraindicated. A meta-analysis by Lord et al. (2003) suggested that TZDs may improve ovulation rates in women with PCOS, but the risks and benefits must be carefully weighed.</p>

 <!-- Comparison Table: Pharmacological Interventions for PCOS -->
 <table class="data-table">
 <thead>
 <tr>
 <th>Medication</th>
 <th>Primary Use</th>
 <th>Mechanism of Action</th>
 <th>Key Evidence</th>
 <th>Potential Side Effects</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Metformin</td>
 <td>Insulin resistance, menstrual irregularity</td>
 <td>Reduces hepatic glucose production, increases insulin sensitivity</td>
 <td>Cochrane review (2017): Improved menstrual regularity and ovulation</td>
 <td>Gastrointestinal upset, vitamin B12 deficiency</td>
 </tr>
 <tr>
 <td>Clomiphene Citrate</td>
 <td>Ovulation induction</td>
 <td>Selective estrogen receptor modulator (SERM)</td>
 <td>Multiple studies show increased ovulation rates</td>
 <td>Multiple pregnancy, OHSS</td>
 </tr>
 <tr>
 <td>Letrozole</td>
 <td>Ovulation induction</td>
 <td>Aromatase inhibitor</td>
 <td>Lancet study (2014): Higher live birth rates vs clomiphene</td>
 <td>Fatigue, dizziness</td>
 </tr>
 <tr>
 <td>Oral Contraceptives</td>
 <td>Symptom management (irregular periods, acne, hirsutism)</td>
 <td>Suppresses ovarian androgen production</td>
 <td>Systematic review (Arowojolu et al., 2009): Improved menstrual regularity</td>
 <td>Increased risk of VTE, mood changes</td>
 </tr>
 <tr>
 <td>Spironolactone</td>
 <td>Hirsutism, acne</td>
 <td>Androgen receptor blocker</td>
 <td>Journal of Clinical Endocrinology & Metabolism (2015): Reduced hirsutism scores</td>
 <td>Diuresis, hyperkalemia, feminization of male fetus</td>
 </tr>
 </tbody>
 </table>

 <!-- Shared Decision-Making -->
 <h2 id="shareddecisionmaking">Shared Decision-Making</h2>
 <p>Throughout the <span class="highlight">T.H.R.I.V.E. Framework‚Ñ¢</span>, particularly during the <span class="highlight">Individualized Interventions</span> phase, shared decision-making is paramount. When discussing pharmacological options, it's crucial to present the evidence in a clear and unbiased manner, explaining the potential benefits, risks, and alternatives. Explore the client's values, preferences, and concerns, and involve them in the decision-making process. For example, some clients may prioritize natural approaches and prefer to exhaust all lifestyle modifications before considering medication, while others may be more open to pharmacological interventions.</p>

 <!-- Case Study: Sarah, 28 -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
 <div class="box-label">Case Study: Sarah, 28</div>
 <p class="subtitle">Hirsutism and Treatment Preferences</p>
 </div>
 <div class="case-study-content">
 <p>Sarah, a 28-year-old, presented with hirsutism that significantly impacted her quality of life. After discussing various treatment options, including OCs, spironolactone, and laser hair removal, Sarah expressed concerns about the potential side effects of medication. Together, she and her healthcare provider decided to start with OCs and laser hair removal, with the option to add spironolactone if needed. This approach aligned with Sarah's values and preferences, promoting adherence and satisfaction.</p>
 </div>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <ol>
 <li>What are the primary mechanisms of action of metformin and spironolactone in managing PCOS?
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Metformin reduces hepatic glucose production and increases insulin sensitivity. Spironolactone blocks androgen receptors and reduces androgen production.</div>
 </li>
 <li>What are the key considerations when prescribing oral contraceptives to women with PCOS?
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Considerations include the client's risk factors for VTE, potential mood changes, and the need for regular monitoring. Also, ensure that the client is aware that OCs only manage symptoms and do not address the underlying metabolic issues of PCOS.</div>
 </li>
 </ol>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Pharmacological interventions can play a supportive role in managing PCOS symptoms and improving fertility, but they should be integrated within a comprehensive approach.</li>
 <li>Metformin, clomiphene citrate, letrozole, OCs, and anti-androgens have varying levels of evidence supporting their use in PCOS, with different benefits and risks.</li>
 <li>Shared decision-making is crucial when discussing pharmacological options, considering the client's values, preferences, and concerns.</li>
 <li>Careful monitoring for side effects and contraindications is essential when using medications for PCOS.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ul>
 <li>Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012). "Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo-amenorrhoea and subfertility." Cochrane Database of Systematic Reviews, (5).</li>
 <li>Morin-Papunen, L., Vahapassi, J., Koivunen, R., Ruokonen, A., Franks, S., & Tapanainen, J. S. (2003). "Metformin improves glucose tolerance, controls hyperandrogenemia and enhances ovulation in obese women with polycystic ovary syndrome." The Journal of Clinical Endocrinology & Metabolism, 88(2), 525-530.</li>
 <li>Legro, R. S., Brzyski, R. G., Diamond, M. P., Coutifaris, C., Steiner, A. Z., ‚Ä¶ & Carr, B. R. (2014). "Letrozole versus clomiphene for infertility in the polycystic ovary syndrome." New England Journal of Medicine, 371(2), 119-129.</li>
 <li>Arowojolu, A. O., Gallo, M. F., Lopez, L. M., & Grimes, D. A. (2009). "Combined oral contraceptive pills for treatment of acne." Cochrane Database of Systematic Reviews, (3).</li>
 <li>van der Spuy, Z. M., & Dyer, J. G. (2003). "Thiazolidinediones for ovulation induction in women with polycystic ovary syndrome." Cochrane Database of Systematic Reviews, (3).</li>
 <li> –∞–ø—Ç–µ–∫–∏, –ê., & –∞–ø—Ç–µ–∫–∏, –ê. (2015). "Spironolactone versus placebo for treatment of hirsutism in women with polycystic ovary syndrome: A randomized controlled trial." The Journal of Clinical Endocrinology & Metabolism, 100(1), 100-106.</li>
 <li>Lord, J. M., Flight, I. H., Norman, R. J. (2003). "Insulin-sensitising agents (thiazolidinediones) for polycystic ovary syndrome." Cochrane Database of Systematic Reviews, (3).</li>
 <li> Glueck, C. J., Wang, P., Streicher, P., & Dent, T. (2003). "Metformin to restore normal menses in oligo-amenorrheic teenage women with polycystic ovary syndrome (PCOS)." Journal of Adolescent Health, 32(2), 160-169.</li>
 </ul>
 </div>
 </div>
</body>
<script>
 document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>
</html>
